The Efficacy of Metformin-based Oral Anti-diabetic Drug is not Inferior to Insulin Glargine in Newly Diagnosed Type 2 Diabetic Patients with Severe Hyperglycemia after Short-term Intensive Insulin Therapy

June 2nd 2014

Considering the metformin’s superiorities in safety, cost and convenience, metformin-based OAD therapy should be strongly recommended for these patients (Journal of Diabetes)

The Efficacy of Metformin-based Oral Anti-diabetic Drug is not Inferior to Insulin Glargine in Newly Diagnosed Type 2 Diabetic Patients with Severe Hyperglycemia after Short-term Intensive Insulin Therapy

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

Glycosmedia is also available as an App:

Sponsorship and Advertising